Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G2-M arrest in A549 cells

Cancer Letters

Volumn 248, Issue 2, 2007, Pages 292-298

  Ikeda, Masato ^a   Okamoto, Isamu ^a   Tamura, Kenji ^b   Satoh, Taroh ^a   Yonesaka, Kimio ^a   Fukuoka, Masahiro ^a   Nakagawa, Kazuhiko ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

Author keywords

G2 M arrest; p53; RNA interference; Survivin; Ultraviolet C

Indexed keywords

PROTEIN P53; SURVIVIN;

ARTICLE; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; DNA DAMAGE; DOWN REGULATION; GENE CONTROL; HUMAN; HUMAN CELL; LUNG CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE; ULTRAVIOLET C RADIATION;

CELL CYCLE; CELL LINE, TUMOR; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 33847313631     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.08.005     Document Type: Article

References (34)

1. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3 (1997) 917-921
2. Li F., and Altieri D.C. Transcriptional analysis of human survivin gene expression. Biochem. J. 344 (1999) 305-311
3. Li F., Ackermann E.J., Bennett C.F., Rothermel A.L., Plescia J., Tognin S., Villa A., Marchisio P.C., and Altieri D.C. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1 (1999) 461-466
4. Monzo M., Rosell R., Felip E., Astudillo J., Sanchez J.J., Maestre J., Martin C., Font A., Barnadas A., and Abad A. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 17 (1999) 2100-2104
5. Adida C., Berrebi D., Peuchmaur M., Reyes-Mugica M., and Altieri D.C. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351 (1998) 882-883
6. Islam A., Kageyama H., Takada N., Kawamoto T., Takayasu H., Isogai E., Ohira M., Hashizume K., Kobayashi H., Kaneko Y., and Nakagawara A. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19 (2000) 617-623
7. Kawasaki H., Altieri D.C., Lu C.D., Toyoda M., Tenjo T., and Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58 (1998) 5071-5074
8. Meng H., Lu C.D., Sun Y.L., Dai D.J., Lee S.W., and Tanigawa N. Expression level of wild-type survivin in gastric cancer is an independent predictor of survival. World J. Gastroenterol. 10 (2004) 3245-3250
9. Zaffaroni N., and Daidone M.G. Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions. Drug Resist. Update 5 (2002) 65-72
10. Asanuma K., Moriai R., Yajima T., Yagihashi A., Yamada M., Kobayashi D., and Watanabe N. Survivin as a radioresistance factor in pancreatic cancer. Jpn. J. Cancer Res. 91 (2000) 1204-1209
11. Honda R., Korner R., and Nigg E.A. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell 14 (2003) 3325-3341
12. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
13. Sionov R.V., and Haupt Y. The cellular response to p53: the decision between life and death. Oncogene 18 (1999) 6145-6157
14. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
15. Ahn J., Murphy M., Kratowicz S., Wang A., Levine A.J., and George D.L. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene 18 (1999) 5954-5958
16. Innocente S.A., Abrahamson J.L., Cogswell J.P., and Lee J.M. p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. USA 96 (1999) 2147-2152
17. Taylor W.R., Schonthal A.H., Galante J., and Stark G.R. p130/E2F4 binds to and represses the cdc2 promoter in response to p53. J. Biol. Chem. 276 (2001) 1998-2006
18. Zhao R., Gish K., Murphy M., Yin Y., Notterman D., Hoffman W.H., Tom E., Mack D.H., and Levine A.J. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14 (2000) 981-993
19. Lu C.D., Altieri D.C., and Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 58 (1998) 1808-1812
20. Sarela A.I., Verbeke C.S., Ramsdale J., Davies C.L., Markham A.F., and Guillou P.J. Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. Br. J. Cancer 86 (2002) 886-892
21. Nakano J., Huang C.L., Liu D., Ueno M., Sumitomo S., and Yokomise H. survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer. Int. J. Oncol. 27 (2005) 1215-1221
22. Yonesaka K., Tamura K., Kurata T., Satoh T., Ikeda M., Fukuoka M., and Nakagawa K. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin. Int. J. Cancer 118 (2005) 812-820
23. 2/M arrest in human cells. Mol. Cell. Biol. 20 (2000) 2358-2366
24. Taylor W.R., and Stark G.R. Regulation of the G2/M transition by p53. Oncogene 20 (2001) 1803-1815
25. Hoffman W.H., Biade S., Zilfou J.T., Chen J., and Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277 (2002) 3247-3257
26. Mirza A., McGuirk M., Hockenberry T.N., Wu Q., Ashar H., Black S., Wen S.F., Wang L., Kirschmeier P., Bishop W.R., Nielsen L.L., Pickett C.B., and Liu S. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21 (2002) 2613-2622
27. Kappler M., Taubert H., Bartel F., Blumke K., Panian M., Schmidt H., Dunst J., and Bache M. Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line. Oncol. Rep. 13 (2005) 167-172
28. Kappler M., Bache M., Bartel F., Kotzsch M., Panian M., Wurl P., Blumke K., Schmidt H., Meye A., and Taubert H. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Ther. 11 (2004) 186-193
29. Beltrami E., Plescia J., Wilkinson J.C., Duckett C.S., and Altieri D.C. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J. Biol. Chem. 279 (2004) 2077-2084
30. Carvalho A., Carmena M., Sambade C., Earnshaw W.C., and Wheatley S.P. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell Sci. 116 (2003) 2987-2998
31. Lens S.M., Wolthuis R.M., Klompmaker R., Kauw J., Agami R., Brummelkamp T., Kops G., and Medema R.H. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J. 22 (2003) 2934-2947
32. Reed J.C. The Survivin saga goes in vivo. J. Clin. Invest. 108 (2001) 965-969
33. Bolton M.A., Lan W., Powers S.E., McCleland M.L., Kuang J., and Stukenberg P.T. Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation. Mol. Biol. Cell 13 (2002) 3064-3077
34. Hauf S., Cole R.W., LaTerra S., Zimmer C., Schnapp G., Walter R., Heckel A., van Meel J., Rieder C.L., and Peters J.M. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 161 (2003) 281-294